The IBD SmartSelect Composite Rating for Carpenter Technology rose from 93 to 96 Wednesday. The specialty steel stock sports ...

Ryan Specialty boasts accelerating growth and rising relative strength. Ryan Specialty stock is nearing a buy point.

Achieving cost sustainability in inflammatory bowel disease (IBD) care requires expanding access to cost-effective treatments ...

Dual biologic therapy may serve as a suitable treatment choice for patients with IBD who have not responded to current therapies.

There is insufficient evidence to support exclusive enteral nutrition as an adjunctive therapy for active ulcerative colitis, ...

A team led by researchers at the University of Toronto has discovered that a compound present in ginger selectively binds to ...

For patients with inflammatory bowel disease (IBD), risk factors associated with Clostridioides difficile infection (CDI) include recent diagnosis, corticosteroid usage, and hospitalization.

A team of researchers has unveiled a revolutionary ingestible bioimpedance sensing device capable of continuously and ...

Individuals’ metabolomic marker profiles may predict the onset of inflammatory bowel disease a decade in advance, underlining ...

Mental health comorbidities are more prevalent among transgender and gender nonconforming adults with IBD than the general and IBD US populations.

A new study published in BMC Gastroenterology identified that patients with inflammatory bowel disease (IBD), such as Crohn's ...

This innovative project aims to enhance remote monitoring and enable early detection of IBD flares through digital biomarkers ...